Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
58.3M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-10.3M
-
Total reported value, excl. options
-
$4.76M
-
Value change
-
-$6.04M
-
Put/Call ratio
-
0.06
-
Number of buys
-
15
-
Number of sells
-
-41
-
Price
-
$0.35
Significant Holders of BioAtla, Inc. - Common Stock, $0.0001 par value per share (BCAB) as of Q1 2025
72 filings reported holding BCAB - BioAtla, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
BioAtla, Inc. - Common Stock, $0.0001 par value per share (BCAB) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 58.3M outstanding shares and own 23.48% of the company stock.
Largest 10 shareholders include ACORN CAPITAL ADVISORS, LLC (4.03M shares), VANGUARD GROUP INC (1.82M shares), ACADIAN ASSET MANAGEMENT LLC (1.69M shares), TANG CAPITAL MANAGEMENT LLC (1.37M shares), RENAISSANCE TECHNOLOGIES LLC (745K shares), MORGAN STANLEY (596K shares), BlackRock, Inc. (594K shares), DEUTSCHE BANK AG\ (525K shares), GEODE CAPITAL MANAGEMENT, LLC (479K shares), and Squarepoint Ops LLC (260K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.